Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/8/25 18:03 | 12/5/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Wong-Sarad Grace | CA | O | Principa | 3 | S | -30 | 1.58 | 0 | -19 | 128 | D | |||||||||||||||
12/3/25 21:06 | 12/3/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Rosenthal Arnon | CA | DO | CEO | 5 | S | -506 | 1.68 | 0 | -300 | 6,437 | D | |||||||||||||||
12/3/25 21:05 | 12/3/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Kenkare-Mitra Sara | CA | O | P,Head o | 5 | S | -247 | 1.71 | 0 | -145 | 565 | D | |||||||||||||||
12/3/25 21:04 | 12/3/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Berkley Neil Lindsay | CA | O | Chief Bu | 2 | S | -81 | 1.53 | 0 | -53 | 374 | D | |||||||||||||||
8/27/25 18:37 | 8/26/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Hammond Paula | CA | D | 1 | S | -33 | 2.36 | 0 | -14 | 75 | D | ||||||||||||||||
6/23/25 16:05 | 6/20/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Yaffe Kristine | CA | D | 1 | S | -1 | 1.44 | 0 | -1 | 95 | D | ||||||||||||||||
6/4/25 16:21 | 6/2/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Grasso Marc | CA | O | CFO | 3 | S | -90 | 1.77 | 0 | -51 | 331 | D | |||||||||||||||
3/5/25 16:05 | 3/3/25 | ALEC | Health | BioPrd | Biological Products, (No Diag | Romano Gary | CA | O | Chief Me | 2 | S | -61 | 1.97 | 0 | -31 | 349 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |